These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8112893)

  • 1. Qualitative and quantitative intratumoral changes in gene expression following cyclophosphamide injection and the adoptive transfer of T cells: the potential contribution of tumor-associated macrophages.
    Evans R; Kamdar SJ; Duffy TM
    Int J Cancer; 1994 Feb; 56(4):568-73. PubMed ID: 8112893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor gene expression after adoptive immunotherapy in a murine tumor model. Regulation of messenger RNA levels associated with the differential expansion of tumor-infiltrating lymphocytes.
    Evans R; Kamdar SJ; Duffy T; Edison L
    J Immunol; 1993 Jan; 150(1):177-84. PubMed ID: 8417123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of class II-MHC antigens by tumor-associated and peritoneal macrophages: systemic induction during tumor growth and tumor rejection.
    Evans R; Blake SS; Saffer JD
    J Leukoc Biol; 1986 Nov; 40(5):499-509. PubMed ID: 3464672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of T- and B lymphocyte responses to mitogens by tumor-associated macrophages: the dependency on the stage of tumor growth.
    Evans R
    J Leukoc Biol; 1984 Jun; 35(6):549-59. PubMed ID: 6610014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.
    Evans R
    Am J Pathol; 1980 Jun; 99(3):667-84. PubMed ID: 7386598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations.
    Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB
    Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic efficacy of murine anti-tumor T cells: freshly isolated T cells are more therapeutic than T cells expanded in vitro.
    Evans R; Kamdar SJ; Duffy TM; Krupke DM; Fuller JA; Dudley ME
    Anticancer Res; 1995; 15(2):441-7. PubMed ID: 7763019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.
    Evans R
    Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in tumor-associated NK 1.1+ large granular lymphocyte precursors after cyclophosphamide injection: in vitro characterization and potential therapeutic application.
    Krupke DM; Fuller J; Aslakson C; Evans R
    Nat Immun; 1994; 13(5):246-57. PubMed ID: 7833624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of immune T lymphocyte function in situ: the identification of active components of the immunologic network during tumor rejection.
    Evans R; Duffy TM
    J Immunol; 1985 Aug; 135(2):1498-504. PubMed ID: 3874236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive immunotherapy is suppressed in C57BL/6J and B6.C-H-2bm12 mice following recognition of congenic class II MHC antigen determinants.
    Evans R; Duffy TM
    Int J Cancer; 1989 Nov; 44(5):854-8. PubMed ID: 2479606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential in situ expansion and gene expression of CD4+ and CD8+ tumor-infiltrating lymphocytes following adoptive immunotherapy in a murine tumor model system.
    Evans R; Duffy TM; Kamdar SJ
    Eur J Immunol; 1991 Aug; 21(8):1815-9. PubMed ID: 1907916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.
    Mihalyo MA; Doody AD; McAleer JP; Nowak EC; Long M; Yang Y; Adler AJ
    J Immunol; 2004 May; 172(9):5338-45. PubMed ID: 15100273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the IL-1 pathway during amplification of immune responses in tumor-bearing mice.
    Evans R; Duffy TM
    Cell Immunol; 1987 Mar; 105(1):86-98. PubMed ID: 3493084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of IL-1 and TNF-alpha expression during the differentiation of bone marrow derived macrophage.
    Myers MJ; Pullen JK; Ghildyal N; Eustis-Turf E; Schook LB
    J Immunol; 1989 Jan; 142(1):153-60. PubMed ID: 2642503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-existing tumor-sensitized T cells are essential for eradication of established tumors by IL-12 and cyclophosphamide plus IL-12.
    Le HN; Lee NC; Tsung K; Norton JA
    J Immunol; 2001 Dec; 167(12):6765-72. PubMed ID: 11739491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of macrophage TNF alpha, IL-1 beta, and Ia (I-A alpha) mRNA expression during peritonitis is site dependent.
    McMasters KM; Cheadle WG
    J Surg Res; 1993 May; 54(5):426-30. PubMed ID: 8361168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.